Optioning your drugs
Article Abstract:
Symphony Capital was started in 2001 and others have designed a biotechnology-funding model that might offer all parties less risk and more benefits. Several analysts believe that innovative models for financing product development are important options for the biotechnology industry.
Publisher: Scientist Inc.
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2006
Financial management, Contracts & orders received, Investment Offices, Investment Companies, Open-End Investment Funds, Investment Funds & Trusts, Contracts & orders let, Finance, Company investment, Investments, Contracts, Contract agreement, Company financing
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
What will your 2006 bonus look like?
Article Abstract:
The trend found in the distribution of annual bonuses in the year 2006 is discussed. Biotechnology companies are expecting their bonuses to increase up to 5%.
Publisher: Scientist Inc.
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2006
Forecasts, trends, outlooks, Personnel administration, Labor Distribution by Employer, Bonus & Merit Payments, Forecasts and trends, Compensation and benefits, Statistics, Surveys, Market trend/market analysis, Bonuses, Compensation (Business), Industry forecasts
Publication Name: The Scientist
Subject: Biological sciences
ISSN: 0890-3670
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Biotechnology industry, Biotechnology industries
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.